Delete search term

To content

Main navigation

Zurich University
of Applied Sciences

Service navigation

Development and bioanalytics of therapeutic mAbs and ADC

Description

In this project, monoclonal therapeutic antibodies and antibody-drug conjugates (ADC) are being developed for the treatment of cancer diseases. The aim of the project is the development and optimization of various bioanalytical methods for the physicochemical characterization of the drug substances with further method development for novel targets and the comparative study of lead candidates.

Key data

Project status

completed, 02/2024 - 12/2025

Institute/Centre

Institute of Chemistry and Biotechnology (ICBT)

Funding partner

Third party

Privacy Settings

Here we show you which services may run on our website. You decide for yourself which services we may use. You can find more information in our privacy notice.

Our website needs these cookies so that everything works properly. These cookies are created automatically when you are active on the site – for example, when you change privacy settings or fill in forms. You can block these cookies in your browser or set it to warn you about them, but some parts of the website will then no longer display correctly. These cookies do not store any of your personal data.

These services allow us to see how our website is used, but we do not know who you are. By activating these services, you help us make the website better for everyone.